CDMC Group


International Society for Protein Termini

Group 3. Diseases of Interest (Inhee Mook-Jung)

Murim Choi / Associate Prof.,  Seoul National University

Research
Disease-associated genomic variants and their mechanistic links with the human pathology, and clues to benefit patient treatment strategy
Publish
19’ EMBO J. 18’ Nat Commun. 17’, 19’ Am J Hum Genet. 18’ Nat Genet. 17’ Ann Neurol.
Field
Identify human gene variants related with degradation process and reveal their functional consequences

Jin Ho Chung / Professor,  Seoul National University

Research
Pathophysiology of skin aging and photoaging; Role of skin-derived factors on health
Publish
17’a, 17’b, 17’c, 19’ J Invest Dermatol.
Field
Investigation and identify skin-derived factors which can improve and prevent degenerative diseases in human

Buhm Han / Associate Prof.,  Seoul National University

Research
Developing algorithms and software packages that contribute to the genomics and bioinformatics research communities to understand of the relationship between genetic variation and traits
Publish
14’, 16’, 18’, 19’ Hum Mol Genet. 19’ Genome Biol. 14’, 15’, 16’ Am J Hum Genet. 16’ Nat Genet.
Field
To apply algorithms and software using large scale genetic and proteomic database related with degradation molecules to understand macroscopic degradation processes and human disorders.

Keon Wook Kang / Professor,  Seoul National University

Research
Molecular imaging and nanomedicine
Publish
19’a,19’b Theranostics 17’a, 17’b Eur J Nucl Med Mol Imaging; 4 registered patents
Field
In vivo molecular imaging of protein ubiquitination and apoptosis

Manho Kim / Professor,  Seoul National University

Research
Stem cell-based cell therapy for neurodegeneration such as Huntington’s disease
Publish
12’, 17’, 19’ Ann Neurol. 18’, 19’, 20’ Ann Clin Transl Neurol. 18’ JAMA Neurol.
Field
To develop stem cell-based therapeutic strategies for neurodegenerative disorders

Youngsoo Kim / Professor,  Seoul National University

Research
Functional Characterization of Biological Pathways using Proteomics Methods. Development of Disease Biomarkers & Multi-marker Panel by Targeted Quantitative Proteomics.
Publish
18’ Clin Chem 17’, 18’ Mol Cell Proteomics 14’ PNAS 14’ Nat Methods 07’~19’ 65 Patent Applications 15’~19’ 32 Patent Registrations including 8 International Patents (3 Europe; 3 USA; 1 Japan, 1 China)
Field
Identify Signaling Pathways and Target Proteins Involved in Degradation Processes and Related Diseases using Targeted & Quantitative Proteomics Techniques.

Obin Kwon / Assistant Prof.,  Seoul National University

Research
To elucidate unknown pathophysiology in metabolic and neuropsychiatric disorders and discover novel therapeutic targets
Publish
18’ Nat Rev Endocrinol. 18’ Cell Rep. 15’ Autophagy 15’ Nat Neurosci.
Field
Develop therapeutic targets for metabolic disorders - diabetes, obesity, and NASH

Seung-Jae Lee / Professor,  Seoul National University

Research
Abnormal protein aggregations and their roles in neurodegeneration
Publish
14’, 18’, 19’ Nat Commun 19’ Brain 19’ J Clin Invest 16’ Autopagy 15’ Nature
Field
To investigate the degradation mechanisms of protein aggregates, and develop diagnostics and therapeutics related with pre-symptomatic neurodegeneration.

Inhee Mook-Jung / Professor,  Seoul National University

Research
Pathophysiologic mechanisms of Alzheimer’s disease
Publish
19’ Cell Metab. 17’, 19’ Nat Commun. 19’ Angew Chem Int Ed Engl 16’, 18’ Autophagy
Field
To investigate the mechanism how defects of protein degradation processes cause the development of Alzheimer’s disease and invent therapeutic targets and tools based on the degradation processes related with neurodegenerative disorders.